N@N

Reflect Scientific: Reflect Scientific Advances to Phase Two Installation of Its Unique Ultra Low Temperature Freezers at a Maj

_{//health-fitness.news-articles.net/content/2009/ .. que-ultra-low-temperature-freezers-at-a-maj.html}
^{Published in Health and Fitness on Monday, July 6th 2009 at 3:40 GMT, Last Modified on 2009-07-06 03:40:53 by Market Wire}  

OREM, UT--(Marketwire - July 6, 2009) - Reflect Scientific, Inc. (OTCBB: [ RSCF ]), a provider of diverse scientific products and services for the biotechnology, pharmaceutical and medical industries, announced the Company is continuing the implementation of its T-150 cryogenic freezing system at a major pharmaceutical manufacturer with a tripling of the installed base. The Cryometrix T-150 technology allows a pharma manufacturer to keep critical product at very low temperatures (typically less than -150° Celsius) for extended periods of time. Maintaining a reliable and cost effective method for storing many important products is crucial to a pharma manufacturer's success. Existing mechanical freezing systems are expensive to operate and maintain.

Moving the testing process to Phase II directly results in the sale of additional freezer units and brings Reflect one step closer to very large freezer orders. Major pharma manufacturers, such as the Company completing this testing phase, often deploy many hundreds of freezers at each facility.

With this validation process and resulting FDA certification now complete, additional T-150 cryogenic freezers can be rapidly installed and certified for operation at this facility.

"The advancement of the T-150 to Phase II is excellent. This further demonstrates the ease of accomplishing c-GMP validation for the Cryometrix system. This implementation program continues to show the reliable, repeatable performance of our energy saving cryogenic freezer and we look forward to continuing our relationship as we progress toward implementing our technology throughout their entire manufacturing organization," remarked Dr. Boyd Bowdish, Principal Scientist for Reflect Scientific.

Mr. Kim Boyce, CEO of Reflect Scientific, remarked, "This repeat order is further confirmation that the T-150 freezer is being accepted and utilized in major markets. The T-150 is key for this customer because it will significantly increase capacity, substantially reduce the overall power consumption of the lab and provide redundancy in the operation. Each of these operational aspects are important attributes to any laboratory with precious and perishable biomaterials. It is our goal to sell thousands of these systems to manufacturers and military installations around the world."

About Reflect Scientific, Inc.

Reflect Scientific, Inc. and its subsidiaries provide products for life science, biotechnology and pharmaceutical industries, as well as tools and analytical services for industrial manufacturing. We develop, manufacture and market refrigeration and cryogenic preservation equipment under our brand name Cryometrix. The Ultra Low Temperature model T-150 is an "all in one" cryogenic freezing system. It is the first liquid nitrogen based, programmable cryogenic freezing system in a standard upright format, which allows for exceptional reliability, precise thermal uniformity, and no user or product exposure to liquid nitrogen. The freezer is optimized for bio-repositories, research, forensic, hospital and clinical laboratories, and other life science applications where refrigeration and cryogenic preservation is required. For more information, visit [ www.reflectscientific.com ].

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.